Please assess the completion status of the following clinical trial:

Trial Title: Spironolactone for Reducing Proteinuria in Diabetic Nephropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~The study is completed. Inclusion criteria was diabetic nephropathy~Exclusion Criteria:~Scr \>2 mg/dl and serum K \> 5meq/L

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: OTHER): None
- 2 (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).